breast tumor
Conditions
Interventions
We will inject 10ml of 0.25% bupivacaine between the PMm and the Pmm ,and 20ml will deposit at the level of the third rib above the serraths anterior muscle.
We will inject 20ml of 0.125% bupivacaine
Sponsors
National Hospital Organization Nagasaki Medical center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients of ASA physical status 1 or 2 schedulede for modified radical mastectomy
Exclusion criteria
Exclusion criteria: 1.Patients whose body weight is less than 50kg 2.Patients who have allegy to the local anesthetics 3.Patients who did not approve participate in this study 4.Inappropriate patients for this study judged by the physicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative NRS after 3,6,12,24,36,48hours | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)the QoR(quality of Recovery)-40 on the day before surgery 2)the QoR-40 1 day after surgery 3)the QoR-40 3 days after surgery 4)consumption of intraoperative opioid 5)evaluation of nerve block area 6)the number of supplemental analgesics 7)the time of initial supplemental analgesics | — |
Countries
Japan
Contacts
Public ContactHiroshi Araki
National Hospital Organization Nagasaki Medical center Department of Anesthesiology
Outcome results
None listed